Synapse - Works

Results (936)

Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): Updated overall survival data after > 5 years of follow-up

Journal Article

D'Angelo, S. P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
ESMO Open (2021)

Fulltext@MSK | Save

Clinical benefit of ripretinib dose escalation after disease progression in advanced gastrointestinal stromal tumor: An analysis of the INVICTUS Study

Journal Article

Zalcberg, J. R.; Heinrich, M. C.; George, S.; Bauer, S.; Schöffski, P.; Serrano, C.; Gelderblom, H.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
The Oncologist (2021)

Fulltext@MSK | Save

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor

Journal Article

Yin, O.; Zahir, H.; French, J.; Polhamus, D.; Wang, X.; van de Sande, M.; Tap, W. D.; Gelderblom, H.; Wagner, A. J.; Healey, J. H.; more...
CPT: Pharmacometrics and Systems Pharmacology (2021)

Fulltext@MSK | Save

Case report: Response to regional melphalan via limb infusion and systemic PD1 blockade in recurrent myxofibrosarcoma: A report of 2 cases

Journal Article

Bartlett, E. K.; D’Angelo, S. P.; Kelly, C. M.; Siegelbaum, R. H.; Fisher, C.; Antonescu, C. R.; Ariyan, C. E.
Frontiers in Oncology (2021)

Fulltext@MSK | Save

Safety and preliminary efficacy of vimseltinib in tenosynovial giant cell tumor (TGCT)

Meeting Abstract

Gelderblom, H.; Abdul Razak, A. R.; Sánchez-Gastaldo, A.; Rutkowski, P.; Wilky, B.; Wagner, A.; van de Sande, M.; Michenzie, M.; Vallee, M.; Sharma, M.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study

Meeting Abstract

von Mehren, M.; Heinrich, C.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

A phase Ia/Ib, dose-escalation/expansion study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma

Meeting Abstract

Gounder, M.; Patel, M. R.; Yamamoto, N.; Bauer, T. M.; Laurie, S.; Perez-Pitarch, A.; Geng, J.; Cheng, J.; Lahmar, M.; Lorusso, P.
Annals of Oncology (2021)

Fulltext@MSK | Save

Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade

Meeting Abstract

Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M.; Gounder, M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

Phase I study of ripretinib, a broad-spectrum KIT and PDGFRA inhibitor, in patients with KIT-mutated or KIT-amplified melanoma

Meeting Abstract

Janku, F.; Bauer, S.; Shoumariyeh, K.; Jones, R. L.; Spreafico, A.; Jennings, J.; Psoinos, C.; Meade, J.; Ruiz-Soto, R.; Chi, P.
Annals of Oncology (2021)

Fulltext@MSK | Save

The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast

Journal Article

Kuba, M. G.; Xu, B.; D’Angelo, S. P.; Rosenbaum, E.; Plitas, G.; Ross, D. S.; Brogi, E.; Antonescu, C. R.
Histopathology (2021)

Fulltext@MSK | Save